Pzena Investment Management LLC Trims Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Pzena Investment Management LLC decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.3% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 986,467 shares of the company’s stock after selling 3,204 shares during the quarter. Pzena Investment Management LLC’s holdings in Henry Schein were worth $71,913,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Cromwell Holdings LLC grew its position in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC purchased a new stake in Henry Schein during the 2nd quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA acquired a new position in shares of Henry Schein in the second quarter valued at approximately $37,000. Blue Trust Inc. raised its stake in shares of Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its position in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

HSIC has been the topic of several analyst reports. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. Robert W. Baird reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Evercore ISI boosted their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Finally, UBS Group reduced their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $78.89.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 22.65 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 1.14% of the company’s stock.

Henry Schein Trading Down 1.9 %

HSIC traded down $1.42 during midday trading on Wednesday, hitting $73.42. The company’s stock had a trading volume of 1,007,516 shares, compared to its average volume of 1,374,825. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The firm has a 50-day moving average price of $70.55 and a two-hundred day moving average price of $69.66. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.15 billion, a P/E ratio of 30.80, a PEG ratio of 1.97 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the firm posted $1.32 EPS. The business’s revenue for the quarter was up .4% compared to the same quarter last year. On average, research analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.